Pharm D Solutions Recalls Lipo MIC-12 Compound Injectable Due to Sterility Concerns
Pharm D Solutions is recalling Lipo MIC-12 Compound Injectable vials nationwide due to a lack of assurance of sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. Per the rubric, FDA Class II recalls with potential for serious injury or hospitalization (implied by sterility failure in injectables) are classified as Severe (4).
Plain-English summary
Pharm D Solutions, LLC is recalling Lipo MIC-12 Compound Injectable, including 10 mL and 30 mL stock solution vials, distributed nationwide. The recall was initiated because of a lack of assurance of sterility for the product.
The affected product includes 896 vials and 64,000 milliliters of the compound injectable. Specific lot numbers and discard dates are listed in the official recall documentation. The product was manufactured in Houston, Texas.
Consumers and healthcare providers should stop using the affected lots and contact Pharm D Solutions or their healthcare provider for further instructions. The FDA has classified this recall as Class II, indicating a reasonable probability that use of the product could cause temporary or medically reversible health consequences.
The recalled product
- Product
- Lipo MIC-12 Compound Injectable a) NDC 69699-1603-10; b) 30 mL Stock Solution Compound Injectable NDC 69699-1603-30, Pharm D Solutions, Houston, Texas
- Manufacturer
- Pharm D Solutions, LLC
- Category
- Drug — Injectable Compound
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot: a) 09042018:66/A Discard by: 3/3/2019
- 07302018:65 Discard by: 1/26/2019
- b) 08132018:75/A Discard by: 2/1/2019
- 04172018:16 Discard by: 9/30/2018
- 03212018:27 Discard by: 9/17/2018
- 04242018:82 Discard by: 10/20/2018
- 05142018:72 Discard by: 11/10/2018
- 06192018:67 Discard by: 12/18/2018
- 08142018:00 Discard by: 2/1/2019
- 07302018:64 Discard by: 1/26/2019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 79 recalled by Pharm D Solutions, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 79 products in this recall →Related recalls
Same manufacturer · Pharm D Solutions, LLC
See all →- SeverePharm D Solutions Recalls Sermorelin/GHRP-2 &6 Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Sermorelin Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls B-Complex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SevereFDA Recalls Ipamorelin Acetate Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Testosterone Cypionate Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22